Top Pharmaceuticals stocks in North America
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
CTLTCatalent | $10.10bn | n/a | n/a |
ROIVRoivant Sciences | $8.97bn | 11.91 | n/a |
ELANElanco Animal Health | $8.40bn | n/a | n/a |
JAZZJazz Pharmaceuticals | $6.91bn | 22.62 | n/a |
ITCIIntra-Cellular Therapies | $6.86bn | n/a | n/a |
IMCRImmunocore Holdings | $5.81bn | n/a | n/a |
BBIOBridgeBio Pharma | $5.45bn | n/a | n/a |
OGNOrganon & Co | $5.25bn | 4.69 | 5.48% |
APLSApellis Pharmaceuticals | $5.10bn | n/a | n/a |
PRGOPerrigo | $4.19bn | 36.99 | 6.25% |
CURACuraleaf Holdings | CA$5.58bn | n/a | n/a |
PBHPrestige Consumer Healthcare | $3.49bn | 22.06 | n/a |
AXSMAxsome Therapeutics | $3.44bn | n/a | n/a |
AMRXAmneal Pharmaceuticals | $3.07bn | n/a | n/a |
CORTCorcept Therapeutics | $2.82bn | 25.29 | n/a |
BHCBausch Health Companies | CA$3.40bn | n/a | n/a |
RNAAvidity Biosciences | $2.48bn | n/a | n/a |
TWSTTwist Bioscience | $2.47bn | n/a | n/a |
VCELVericel | $2.34bn | 5031.38 | n/a |
AMPHAmphastar Pharmaceuticals | $2.06bn | 15.73 | n/a |